Skip to main content

Table 3 Survival by miRNA expression for 39 dysregulated miRNAs (from Table 1)a,b,c,d

From: Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis

No.miRNAHR95% CIP-value
1hsa-miR-30e*0.760.61–0.950.0179
2hsa-miR-1240.790.62–1.000.0459
3hsa-miR-221.220.95–1.560.1166
4hsa-miR-140-3p0.840.67–1.050.1303
5hsa-miR-1430.850.68–1.060.1487
6hsa-miR-1500.850.67–1.080.1924
7hsa-miR-106b1.160.92–1.450.2022
8hsa-miR-2031.150.92–1.440.2197
9hsa-miR-5960.870.69–1.090.2285
10hsa-miR-30a*0.880.71–1.090.2389
11hsa-miR-23b0.880.70–1.100.2638
12hsa-miR-183*1.150.89–1.480.2763
13hsa-miR-2040.880.69–1.120.2852
14hsa-miR-486-5p0.890.69–1.130.3295
15hsa-miR-196b0.890.71–1.130.3435
16hsa-miR-1450.900.73–1.120.3544
17hsa-miR-133b0.900.72–1.120.3565
18hsa-miR-133a0.900.72–1.130.3815
19hsa-miR-26b*0.890.68–1.180.4180
20hsa-miR-21*1.090.87–1.370.4533
21hsa-miR-885-5p1.080.85–1.380.5286
22hsa-miR-130b1.080.84–1.390.5384
23hsa-miR-6391.090.83–1.430.5404
24hsa-miR-21*1.070.86–1.340.5411
25hsa-miR-423-5p1.070.84–1.370.5707
26hsa-miR-950.940.74–1.190.5844
27hsa-miR-7080.950.75–1.200.6622
28hsa-miR-378*1.050.84–1.320.6677
29hsa-let-7c0.950.76–1.200.6779
30hsa-miR-3280.950.74–1.210.6869
31hsa-miR-574–3p0.950.75–1.210.6977
32hsa-miR-139-5p0.960.77–1.200.7210
33hsa-miR-3751.040.81–1.330.7731
34hsa-miR-1490.970.76–1.220.7813
35hsa-miR-125b0.970.77–1.230.8095
36hsa-miR-99a*1.010.81–1.260.9020
37hsa-miR-422a0.990.79–1.230.9074
38hsa-miR-1001.010.80–1.260.9548
39hsa-miR-3781.000.80–1.260.9770
  1. amiRNA expression modeled as tumor/normal fold change using ordinal variable (0,1,2,3)
  2. bmiRNAs shown in ascending order by P-value
  3. cCox proportional hazards models adjusted for age, gender, metastasis, stage
  4. dAssociations P < 0.05 are bolded and italicized